Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference

CAMBRIDGE, Mass., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, September 26 at 3:00 p.m. ET. Momenta will provide a company overview and program update, including comments on necuparanib (formerly M402), biosimilars and M356, the Company's generic version of Copaxone developed in collaboration with Sandoz.

The audio webcast of the presentation will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.

http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=871296